Hemic and Lymphatic Diseases: News and Research on Myeloproliferative Disorders

MeSH tree: C15.378.190.636

Closing in on a cure for common leukemia

A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.

Researchers use a new approach to hit an 'undruggable' target

The protein STAT5 has long been an appealing target against cancer, but after decades of research it was consigned to the "undruggable" category. Now, University of Michigan Rogel Cancer Center researchers have found success ...

page 4 from 5